XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 27,815 $ 27,551
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 12,908 10,983
Bad debt provision 79,012 36,848
Deferred income taxes 15,939 (1,612)
Share-based compensation expense 8,881 6,828
Amortization of premium on marketable securities 359 1,003
Unrealized gain on deferred compensation fund investments (6,926) (7,809)
Changes in other long-term liabilities (384) (524)
Net loss on disposals of property and equipment 253 507
Share of losses from equity method investment 2,386 197
Changes in operating assets and liabilities:    
Accounts and notes receivable 5,255 (57,909)
Inventories and supplies (453) 1,434
Prepaid expenses and other assets (3,603) (3,503)
Deferred compensation funding 469 (27)
Accounts payable and other accrued expenses (5,310) (10,904)
Accrued payroll, accrued and withheld payroll taxes (134) (12,820)
Deferred ERC credits 12,276 0
Income taxes receivable/payable (23,953) (2,700)
Accrued insurance claims (4,115) (1,348)
Deferred compensation liability 6,906 8,403
Net cash provided by (used in) operating activities 127,581 (5,402)
Cash flows from investing activities:    
Disposals of property and equipment 86 193
Additions to property and equipment (4,438) (4,909)
Cash paid for acquisition (7,287) 0
Cash paid for investments (2,125) (2,750)
Purchases of marketable securities (13,884) (51,490)
Sales of marketable securities 8,082 43,205
Net cash used in investing activities (19,566) (15,751)
Cash flows from financing activities:    
Purchases of treasury stock (41,982) (4,008)
Payments of statutory withholding on net issuance of restricted stock units (1,744) (1,030)
Net cash used in financing activities (43,726) (5,038)
Net increase (decrease) in cash, cash equivalents and restricted cash equivalents 64,289 (26,191)
Cash, cash equivalents and restricted cash equivalents at beginning of the period 60,131 54,330
Cash, cash equivalents and restricted cash equivalents at end of the period $ 124,420 $ 28,139